PRISM BioLab Co.,LTD (TYO:206A)
Japan · Delayed Price · Currency is JPY 186.00
-6.00 (-3.13%)
At close: Feb 6, 2026
PRISM BioLab Co.,LTD Market Cap
PRISM BioLab Co.,LTD has a market cap or net worth of 6.87 billion as of February 6, 2026. Its market cap has decreased by -41.21% in one year.
Market Cap
6.87B
Enterprise Value
3.95B
Revenue
677.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
186.00
Market Cap Chart
Since July 2, 2024, PRISM BioLab Co.,LTD's market cap has decreased from 17.84B to 6.87B, a decrease of -61.49%. That is a compound annual growth rate of -44.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 6.87B | 19.29% |
| Dec 30, 2025 | 5.76B | -44.77% |
| Dec 30, 2024 | 10.43B | -41.56% |
| Jul 2, 2024 | 17.84B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MEDINET | 7.94B |
| CellSource | 7.87B |
| ADR120S | 7.76B |
| Chiome Bioscience | 7.73B |
| BrightPath Biotherapeutics | 7.68B |
| OncoTherapy Science | 7.53B |
| Linical | 7.09B |
| TMS Co., Ltd. | 6.46B |